🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-523127-21-00
Ongoing Phase I

A Study to Evaluate Targeted Therapies for Patients with Rheumatoid Arthritis

2025-523127-21-00 · tracked via the Priya Life Science EU tracker
Sponsor
AbbVie Deutschland GmbH & Co. KG
Sponsor type
Pharmaceutical company
Therapeutic area
Immune System Diseases
Decision date
01/07/2026
Enrollment target
19
Sites
Belgium, Netherlands, Spain, Germany, Italy

Condition studied

Rheumatoid Arthritis

Eligibility

Age group
65+ years, 18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-523127-21-00 on CTIS ↗ ← All trials in the EU